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Dear Editor,
Ravaghi et al. should be congratulated for offering a 
fascinating insight into the views of senior managers on the 
implementation of clinical governance (1). Clearly many had 
experience of challenges in implementation and there were 
different types of challenges. However, a common theme ran 
through many of the challenges, and that theme is one of cost. 
The managers did not mention cost explicitly but the issue was 
clearly implicit. They spoke of the need for more resources, 
support and staff engagement—all of which are associated with 
costs. We would do well to ask outright: what are the costs of 
implementing clinical governance? Such costs are likely to be 
significant, and are likely to be made up of all the components 
of clinical governance including, as the authors outline, “clinical 
effectiveness, clinical audit, risk management, patient and 
public involvement, education and training, staff management, 
and use of information” (2).
Each of these is expensive—not least education and training 
of staff. To justify such costs, healthcare systems need to see 
real outcomes from clinical governance in terms of improved 
quality of care for patients and the public. Perhaps this 
perspective should make us re-focus our clinical governance 
efforts upon clinical quality improvement and cost efficiency. 
Clinical quality improvement may in fact go hand in hand 
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with cost efficiency. If individual healthcare professionals and 
teams concentrate their efforts on areas where institutions need 
to improve then that would be a good start. They could then 
measure quality at baseline, put measures in place to improve 
quality and continually re-measure. In the medium to long-term 
quality improvement processes should be embedded. If done 
properly, quality improvement should save costs. It should cut 
out inefficient practices and prevent expensive medical errors. 
Individuals and teams should share their learning throughout 
institutions and ensure that mistakes are not repeated and that 
in effect organisations as a whole learn. 
If we do not take this approach, clinical governance will likely 
become an ever ballooning cost. If we do, clinical governance 
will develop focus, and with such focus, will come tangible 
benefits through quality improvement and cost saving. 
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